Seeking Alpha

drgmoney

drgmoney
Send Message
View as an RSS Feed
View drgmoney's Comments BY TICKER:
Latest  |  Highest rated
  • Wednesday's Vote Will Determine Dendreon's Fate [View article]
    How does this guy who clearly does not have a clue about Provenge get an article posted to SA and carried to the Yahoo wires and SaulK doesn't? Crazy world. Dr G
    Nov 16, 2010. 05:40 PM | 5 Likes Like |Link to Comment
  • Dendreon Update [View instapost]
    Thanks for another great read - just wish I had double clicked on a Yahoo headline to get here. Dr G
    Aug 9, 2010. 05:49 PM | 5 Likes Like |Link to Comment
  • Dendreon, The Fabled "Next Amgen"  [View instapost]
    I agree that Dendreon is on sale right now. Wait until the NJ plant is fully operational!
    Jul 9, 2010. 08:59 AM | 3 Likes Like |Link to Comment
  • Dendreon: Fear is Our Friend [View instapost]
    Looking for this one on the Yahoo wires......
    Jul 7, 2010. 04:00 PM | 11 Likes Like |Link to Comment
  • Access Pharma Looking for Smooth U.S. MuGard Launch in 2010 [View article]
    Do you know if the post marketing Data on Mugard in Europe will be published in a peer review journal??
    Nov 12, 2009. 09:31 AM | Likes Like |Link to Comment
  • Access Pharma: Deep Pipeline, Shallow Valuation [View article]
    Mike, have you heard anything in regards to Milestone beginning marketing of mugard in the US? It has been approved for more than a year
    Jul 15, 2009. 09:44 AM | Likes Like |Link to Comment
  • Seven New Extreme Biotech Trades [View article]
    JAV also has a intranasal ketamine product called Ereska with phase III data due in next few weeks and plan to file an NDA for this as well if data are good. so possibly 2 NDA's in next 6 months. Dyloject will complete with Toradol the only FDA approved intravenous NSAID. disclosure: own JAV
    Jun 19, 2009. 02:00 PM | Likes Like |Link to Comment
  • FDA Calendar Updates: Transdel, Javelin, Jazz, Par Pharma [View article]
    Also have Phase III safety data due this summer to support their NDA for dyloject which should be good as previous Phase III trials had superior safety data to toradol
    Jun 18, 2009. 01:27 PM | Likes Like |Link to Comment
  • FDA Calendar Updates: Transdel, Javelin, Jazz, Par Pharma [View article]
    Don't forget JAV is due to release phase III results for their intranasal ketamine product ERESKA in the next few weeks.
    Jun 18, 2009. 01:25 PM | Likes Like |Link to Comment
COMMENTS STATS
9 Comments
25 Likes